Compass Therapeutics Inc. banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United States of America US
Employees
39
IPO date
Nov 13, 2020

Compass Therapeutics is a biotechnology company that develops antibody-based drugs, mainly for cancer. Its work centers on finding immune and tumor targets, designing antibodies that can bind to those targets, and testing these candidates in clinical trials. The company does not sell consumer products; its business is built around discovering and advancing medicines that could become prescription therapies.

The company’s main customers are not patients directly, but larger drug companies, hospitals, and eventually doctors and health systems if a drug wins approval. Today it makes money mainly through research partnerships, licensing deals, and the long path to possible future drug sales if its own programs succeed. That means most of its value comes from its pipeline of experimental medicines rather than from a broad commercial product line.

What makes Compass different is its focus on antibody science and on hard-to-treat cancers. In this industry, a company like Compass acts as a drug developer that takes early research forward to the point where a larger partner may help fund development, or where the company itself can pursue approval and commercialization. Its role is to turn lab discoveries into medicines that can be tested in real patients.

Compass Therapeutics Inc. Investor Relations

Address
80 Guest Street
Boston, Massachusetts
United States of America

Business Segments

Cancer drug development

Compass Therapeutics develops antibody-based medicines for cancer. It runs lab research and clinical testing to find treatments that can block signals tumors use to grow and can help the immune system attack cancer.

Customers and revenue model

Management

Dr. Thomas J. Schuetz M.D., Ph.D.

Chief Executive Officer

Biography unavailable

Ms. Vered Bisker-Leib MBA, Ph.D.

Advisor

Biography unavailable

Mr. Neil L. Lerner CPA

Vice President of Finance

Biography unavailable

Mr. Jonathan Anderman J.D.

VP, Head of Legal & Corporate Secretary

Biography unavailable

Anna Gifford

Communications Manager

Biography unavailable

Dr. Minori Rosales M.D., Ph.D.

Senior VP & Head of Clinical Development

Biography unavailable

Ms. Karin Herrera B.A.

VP & Head of Clinical Operations

Biography unavailable

Dr. James Kranz Ph.D.

VP and Head of Chemistry Manufacturing & Controls

Biography unavailable

1 / 8